Camurus AB (publ) (STO:CAMX)
669.00
-16.00 (-2.34%)
Aug 1, 2025, 5:29 PM CET
Camurus AB Employees
Camurus AB had 256 employees as of December 31, 2024. The number of employees increased by 43 or 20.19% compared to the previous year.
Employees
256
Change (1Y)
43
Growth (1Y)
20.19%
Revenue / Employee
8.49M SEK
Profits / Employee
2.69M SEK
Market Cap
39.75B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 256 | 43 | 20.19% |
Dec 31, 2023 | 213 | 37 | 21.02% |
Dec 31, 2022 | 176 | 28 | 18.92% |
Dec 31, 2021 | 148 | 14 | 10.45% |
Dec 31, 2020 | 134 | 14 | 11.67% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,296 |
Getinge AB | 11,791 |
Medicover AB | 47,256 |
Asker Healthcare Group AB | 4,030 |
Bonesupport Holding AB | 139 |
AddLife AB | 2,181 |
Vitrolife AB | 1,169 |
Camurus AB News
- 6 weeks ago - Camurus' POSITANO study shows treatment effects with CAM2029 in polycystic liver disease patients - PRNewsWire
- 2 months ago - Camurus and Lilly enter collaboration and license agreement for long-acting FluidCrystal® incretins - PRNewsWire
- 3 months ago - CHMP recommends approval of Oczyesa® for treatment of acromegaly in the EU - PRNewsWire
- 9 months ago - Camurus AB (CAMRF) Q3 2024 Earnings Call Highlights: Record Profit and Revenue Growth Amid ... - GuruFocus
- 9 months ago - Q3 2024 Camurus AB Earnings Call Transcript - GuruFocus
- 10 months ago - US FDA declines to approve Camurus' rare hormone disorder drug - Reuters
- 1 year ago - New publication shows effectiveness data for weekly and monthly buprenorphine injections in treating opioid dependence in individuals using fentanyl - PRNewsWire